Bayforest Capital’s Travere Therapeutics TVTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$52.6K Buy
+894
New +$54.6K 0.08% 473
2026
Q2
– Sell
-3,512
Closed -$104K – 1212
2026
Q1
$104K Buy
+3,512
New +$105K 0.12% 347

Other funds holding TVTX

Bayforest Capital's TVTX Position: Q3 2026 in Review

Bayforest Capital opened a new position in Travere Therapeutics (TVTX) in Q3 2026: 894 shares worth $52.6K. The stake represents 0.08% of the portfolio and ranks #473 among its holdings. This is a return to the name: Bayforest Capital previously reported a position in TVTX as recently as Q1 2026.

Bayforest Capital first reported a position in TVTX in Q1 2026 and has held it in 2 quarters since. The position peaked at $104K in Q1 2026. 251 funds tracked by Wall St. Rank hold TVTX as of Q3 2026.

  • Bayforest Capital held 894 shares of Travere Therapeutics worth $52.6K as of Q3 2026.
  • Travere Therapeutics was a new Bayforest Capital position in Q3 2026.
  • Travere Therapeutics made up 0.08% of Bayforest Capital's portfolio in Q3 2026, its #473 holding.
  • Bayforest Capital first reported a position in Travere Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • Bayforest Capital's Travere Therapeutics position peaked at $104K in Q1 2026.
  • 251 funds tracked by Wall St. Rank held Travere Therapeutics as of Q3 2026.

Based on Bayforest Capital's 13F filing for Q3 2026, filed 3 Nov 2026.